FDA reviewing first of three weight loss drugs

FDA reviewing first of three weight loss drugs
WASHINGTON — Dieters, doctors and investors get their first extensive look at the first of a trio of new weight loss drugs this week. The hope is that the new drugs can succeed where many others have failed: delivering significant weight loss without risky side effects. With U.S.
Read more on The Monterey County Herald